Personalized medicine in genetic epilepsies – possibilities, challenges, and new frontiers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Personalized medicine in genetic epilepsies – possibilities, challenges, and new frontiers

Published:2020-08 Issue: Volume:172 Page:107970
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Helbig Ingo^ORCID,Ellis Colin A.

Funder

NIH

National Research Service Award (NRSA) Institutional Research Training

Epilepsy NeuroGenetics Initiative

German Research Foundation

European Science Foundation

DFG

National Institute for Neurological Disorders and Stroke

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference89 articles.

1. Drug-resistant epilepsy classified by a phenotyping algorithm associates with NTRK2;Almoguera;Acta Neurol. Scand.,2019

2. Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency;Arsov;Epilepsia,2012

3. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy;Barcia;Nat. Genet.,2012

4. Targeted treatment of migrating partial seizures of infancy with quinidine;Bearden;Ann. Neurol.,2014

5. Remarkable phenytoin sensitivity in 4 children with SCN8A-related epilepsy: a molecular neuropharmacological approach;Boerma;Neurotherapeutics,2016

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the genetic basis of epilepsy: Recent advances and implications for diagnosis and treatment;Brain Research;2024-11

2. Diagnostic evaluation of patients with epileptic spasms in the era of next‐generation sequencing;Epileptic Disorders;2024-07

3. KCNT1 Channel Blockers: A Medicinal Chemistry Perspective;Molecules;2024-06-20

4. Revolutionizing Neurological Disorder Treatment: Integrating Innovations in Pharmaceutical Interventions and Advanced Therapeutic Technologies;Current Pharmaceutical Design;2024-05

5. Face-valid phenotypes in a mouse model of the most common mutation in EEF1A2-related neurodevelopmental disorder;Disease Models & Mechanisms;2024-02-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3